LTBR and chronic myelogenous leukemia, BCR-ABL1 positive: Lymphotoxin-β receptor (LTβR) is a tumor necrosis factor-alpha (TNFα) receptor superfamily member and its loss of function has been shown to decrease LSCs numbers and extend survival in a CML animal model.